-
my country's own original lung cancer targeted drugs show advantages in treating lung cancer brain metastases
Time of Update: 2021-07-06
Medical Network News, March 24, recently, China's independent research and development of the third-generation lung cancer targeted therapy for EGFR (epidermal growth factor receptor) mutations Ivesa (Vometinib mesylate) was awarded the National Medical Products Administration Approval for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have experienced disease progression during or after treatment with targeted drugs for EGFR mutations and confirmed to have EGFR T790M mutation-positive .
-
Prolong the "cancer-free survival" of early lung cancer immunotherapy can reduce the risk of recurrence
Time of Update: 2021-07-06
The results showed that compared with the best supportive therapy, atezolizumab as an adjuvant therapy in patients with stage II-IIIA NSCLC with tumor PD-L1 expression >1% reduced the risk of disease recurrence or death by 34% (HR=0.
-
Two-way brain-computer interface stimulates the brain to evoke the sense of touch and improve the ability to operate prosthetics
Time of Update: 2021-07-06
In a paper published on the 20th in the journal Science, a team of bioengineers at the University of Pittsburgh Rehabilitation Neural Engineering Laboratory described a new application of brain-computer interface technology, that is, how to arouse the sense of touch by increasing brain stimulation, thereby It makes it easier for the operator to manipulate the mechanical arm controlled by the brain .
-
All 3 specifications of Enhua Pharmaceutical Duloxetine Hydrochloride Enteric-coated Capsules have passed the approval!
Time of Update: 2021-06-29
On the 18th, Enhua Pharmaceutical announced that the company has recently obtained the "Drug Registration Certificate" for the psychotropic drug duloxetine hydrochloride enteric-coated capsules 20mg, 30mg, and 60mg approved and issued by the National Medical Products Administration .
-
China National Medical Products Administration: The five-dimensional calcium calcium oral solution is converted from prescription drugs to non-prescription drugs
Time of Update: 2021-06-29
The list of varieties and the template of non-prescription drug instructions will be released together .
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents .
-
2021 "smart + interconnection" accelerates the empowerment of scientific instrument salons to ignite the spark of thought
Time of Update: 2021-06-28
Analysis and Testing Encyclopedia Newsletter June 20, 2021, the 2021 "smart + interconnection" accelerated empowerment scientific instrument salon hosted by the Analytical Instrument Branch of the Ch
-
Potential molecular targets can treat obesity-related metabolic disorders
Time of Update: 2021-06-28
On June 10, a reporter from the Science and Technology Daily learned from Wuhan University that researchers from the Zhongnan Hospital of the school discovered that a lysosomal-related protein TMBIM1 has a key negative regulatory effect on adipogenesis and is a potential molecular target for the treatment of obesity-related metabolic disorders .
-
Guangzhou epidemic on June 14: two medical staff positive for new crown nucleic acid; high school entrance examination postponed
Time of Update: 2021-06-22
As of 24:00 on June 13, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 471 confirmed cases (including 13 severe cases), a total of 86,344 cured and discharged cases, and a total of 4,636 deaths.
-
Rao Yi speaks again: China's support for young people in the past 30 years
Time of Update: 2021-06-22
It needs to be improved in reform, not abolished] text: In 1994, the National Natural Science Foundation of China launched the "Outstanding Youth Fund" to select and support young people under the age of 45 .
-
Two medical workers in Guangzhou infected with the new crown virus
Time of Update: 2021-06-22
Nucleic acid tests have been performed on all the original medical staff and relevant environmental samples from the eighth city hospital, and the results are all negative .
-
Listen to users, keep making progress, SCIEX clinical mass spectrometry is deeply rooted in the people's hearts
Time of Update: 2021-06-22
In this training class, Analysis and Testing Encyclopedia interviewed Wang Ya, the development director of SCIEX's marketing department, and asked her to introduce us the products and technologies brought by the company in this training class .
-
Russia has developed an anti-hantavirus drug that is 5 times more effective than existing drugs
Time of Update: 2021-06-22
Chemists from the People’s Friendship University of Russia, together with colleagues from Novosibirsk State University and the Novosibirsk Institute of Organic Chemistry, based on the VECTOR Center for Scientific Virology, obtained a new class of compounds that can inhibit the division of the deadly Hantavirus (the The virus affects human blood vessels and internal organs) .
-
Guangdong pharmacies, while escorting the fight against the epidemic, have undergone "the strictest supervision"
Time of Update: 2021-06-22
Retail pharmacies must strictly implement prevention and control measures such as showing the health code when entering the store .
-
AstraZeneca vaccine adds potential side effects: rare blood disease after vaccination
Time of Update: 2021-06-22
According to a Reuters report on the 12th, the European Medicines Agency recently listed another rare blood disease-capillary leak syndrome (CLS) as a potential side effect of AstraZeneca's new crown vaccine .
-
Postgraduate’s confusion: Is it better to read literature or do experiments?
Time of Update: 2021-06-22
For graduate students to start the research work of the dissertation, the general supervisor will first arrange to read the literature in the relevant field, through the process and links of reading, discussing with the supervisor, and communicating within the research group, complete the opening report, and then start the experimental work .
-
Nanjing Pinsheng Medical 9000 mass spectrometer unveiled at Shanghai Zhongshan Hospital Clinical Application Exhibition
Time of Update: 2021-06-22
In this training class, Analysis and Testing Encyclopedia interviewed Lin Xi, product manager of Nanjing Biomedical, Medical Marketing Department, and asked him to introduce the products and technologies displayed by the company in this training class .
mp4" type="video/mp4"> Nanjing Pinsheng Medicine is an in vitro high-tech diagnostic company specializing in clinical mass spectrometry .
-
618 Agilent consumables laboratory shopping festival, purchasing frenzy, now begins
Time of Update: 2021-06-21
618 Agilent consumables laboratory shopping festival, purchasing frenzy, now begins Follow the president to buy consumables, not only the lowest price, but also multiple gifts, waiting for you!
The expert recommended must-buy list is not to be missed .
-
U.S. FDA accelerates approval of innovative treatments for Alzheimer's disease
Time of Update: 2021-06-21
S. Food and Drug Administration (FDA) approved Aduhelm (aducanumab) for the treatment of Alzheimer's disease (AD) patients through accelerated approval .
S. Food and Drug Administration (FDA) approved Aduhelm (aducanumab) for the treatment of Alzheimer's disease (AD) patients through accelerated approval .
-
Listening to music before going to bed, the more you listen, the more tired you are, it turns out that the "earworm" is at work
Time of Update: 2021-06-21
" The study investigated the sleep quality, music listening habits, and frequency of hearing "earworms" of 209 participants, including how often they heard "earworms" when trying to fall asleep, waking up in the middle of the night, and just waking up in the morning .
-
China's self-developed ADC new drug approved for marketing for gastric cancer treatment
Time of Update: 2021-06-21
The reporter learned from the Management Committee of Yantai Development Zone on the 10th that China's first original antibody-conjugated drug (ADC) new drug-vedicitumumab, declared by Rongchang Biopharmaceutical (Yantai) Co.
